Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
DefenCell (Cell-Logic Pty Ltd)
Product Name
DefenCell
Sponsor
ARTG
Date of review outcome
Date of publication
Jun-22
Outcome
Medicine continues to be permitted for supply
Is it safe to continue using this medicine?
Yes, based on the sponsor's certification
What action should consumers take?
Be aware that the medicine may not work as expected in relation to 'improving cardiovascular health’ and 'boosting cellular antioxidant and detoxification defences’
Review scope
Random
Information reviewed
ARTG Record, Evidence, Labels, Manufacturing Documentation, Website
Issues related to safety
None
Issues related to efficacy
The website claimed that the medicine may 'improve cardiovascular health’ and 'boost cellular antioxidant and detoxification defences’. However, these claims were not covered by the sponsor’s certification that they held evidence to substantiate them.
Actions taken during the review
The TGA required the sponsor to correct the issues with the medicine. The sponsor provided more information and updated the label and website for the medicine to correct the issues.